Functional extra-adrenal paraganglioma of the retroperitoneum giving thoracolumbar spine metastases after a five-year disease-free follow-up: a rare malignant condition with challenging management

Functional extra-adrenal paraganglioma of the retroperitoneum giving thoracolumbar spine metastases after a five-year disease-free follow-up: a rare malignant condition with challenging management

Stylianos Kapetanakis^1,&, Danai Chourmouzi², Grigorios Gkasdaris¹, Vasileios Katsaridis³, Eleftherios Eleftheriadis⁴, Panagiotis Givissis⁵

 

¹Spine Department and Deformities, Interbalkan European Medical Center, Thessaloniki, Greece, ²Radiology Department, Interbalkan European Medical Center, Thessaloniki, GreeceNeurosurgery Department, Interbalkan European Medical Center, Thessaloniki, Greece, ³Pathology Department, Interbalkan European Medical Center, Thessaloniki, Greece, ⁴First Orthopaedic Department of ’Aristotle University of Thessaloniki’, ’Papanikolaou’ Hospital, Exohi, Thessaloniki, Greece

 

 

^&Corresponding author
Stylianos Kapetanakis, Spine Department and Deformities, Interbalkan European Medical Center, Thessaloniki, Greece

 

 

 

 

Paragangliomas, also known as extra-adrenal pheochromocytomas, are neuroendocrine tumors that arise from chromaffin cells of the adrenal medulla and from neuroendocrine cells of the extra-adrenal autonomic paraganglia, with the majority of the tumours being benign in nature [1]. There have been several reports of metastatic paraganglioma in the literature, but rarely do such tumors metastasize to the spine [2, 3]. In this case report, the patient was diagnosed with a metastatic lesion in T4 vertebra after five disease-free years from the initial resection of a retroperitoneal paraganglioma.

 

 

A 48-year-old man was admitted with the complaints of worsening back pain, palpitation, headache and sweating. He denied any trauma or weakness in his extremities. On physical examination he had point tenderness in his thoracic vertebrae and blood pressure 185/84 mm Hg. The patient had a history of a retroperitoneal paraganglioma that was discovered by chance at the age of 43 as an abdominal mass. No family history of paraganglioma was detected. The lesion was completely resected through laparotomy and the patient was found to be disease-free at follow-ups. When admitted to our hospital, laboratory tests revealed elevated serum normetanephrine and norepinephrine. CT scan revealed a lytic lesion involving the T4 vertebral body (Figure 1 A). On MRI, a compression fracture of the vertebral body with small epidural component was depicted (Figure 1 B,C). The supposed spinal metastatic functional paraganglioma was confirmed by computed tomography guided needle biopsy (Figure 1 D). The histologic and immunohistochemical assays revealed a paraganglioma (Figure 2 A,B). The patient displayed significant improvement in pain after radiosurgical treatment. Also, the patient underwent somatostatin analogs therapy and showed symptomatic and biochemical improvement as well. However, MRI revealed small new lesions in lumbar spine 6 months later (Figure 3 A,B,C). Treatment with combination chemotherapy for the management of the disease is now under discussion by a multidisciplinary team.

 

 

Most commonly, paragangliomas are seen within the adrenal medulla giving rise to pheochromocytoma and only 10% of paragangliomas arise outside the adrenal glands. They can be functional with symptomatology of paroxysmal hypertension, palpitation, headache, sweating or be detected as non-functional, asymptomatic and slow-growing [4]. It is hard to make a correct initial diagnosis. CT, MRI or ultrasonography are capable of detecting a retroperitoneal mass, however diagnosis of the retroperitoneal mass still relies on the postoperative histopathological results, since benign and malignant paragangliomas may exhibit similar clinical symptoms and imaging findings. Apart from central necrosis, vascular and lymphatic invasion and mitotic abnormalities; chromogranin A, vimentin, S-100, synaptophysin can be used in the immunohistochemical analysis of paragangliomas and indicate the true nature of the tumour [3]. In our case, vascular invasion and increased number of mitoses were observed and also the tissue was positive for chromogranin A. Malignant paraganglioma is a rare presentation diagnosed by local recurrence after total resection of the primary mass or findings of distant metastasis [3, 5]. The time intervals for recurrence may be from months to many years. In our report, the patient presented a metastatic lesion five years after the initial resection. Several authors report that vertebral metastases from malignant paragangliomas of the retroperitoneum are rare and late in their emergence as well. Kitagawa et al reported a case of T6 metastasis from retroperitoneal paraganglioma 9 years after the primary surgery [6]. Doza et al reported local recurrence and vertebral metastases 10 years after first surgical resection [7]. Awareness of imaging manifestations of spinal metastatic disease is essential. We consider that in cases like this, MRI is the most useful imaging technique; because contrary to x-rays, bone scintigraphy and CT scans, it allows both direct visualization of bone marrow involvement with high spatial resolution, as well as, early diagnosis of possible neural compression [8]. In comparison to a similar case management by He et al our patient did not have any SPECT (single photon emission computed tomography) imaging [3].

 

In order to reach a histological confirmation of the metastatic lesion, core needle biopsy under CT guidance was performed. We decided to the use of this technique as a confirmation tool, because it is considered a simple, minimally invasive method, with high levels of diagnostic accuracy in cases of suspected spinal metastatic lesion [9]. In the literature, two types of lesions have been described. Expanding lesions are characterized by cortical destruction with bone marrow and soft tissue involvement, while nodular lesions present a specific radiological appearance, consisting of a central low-intensity signal surrounded by a single fat-like halo or a double halo with a fat-density inner circle and an outer circle suggestive of edema. In some patients, these lesions can coexist [10]. The patient was diagnosed with an expanding lesion on T4 vertebral body and six months later with nodular lesions involving lumbar vertebrae. In our opinion, expanding form of metastasis is related to evolution from the nodular form and coexistence is seen in the progressive disease. As regards to treatment, while the individual behavior of a paraganglioma is unpredictable, the primary therapeutic option should be directed towards the complete surgical resection of the primary tumor with meticulous preservation of vital neurovascular structures [11]. Our case was treated in a similar way concerning the primary site. When metastatic, it is believed that vertebral metastases with neural compression should be treated with decompressive surgery and total en bloc spondylectomy. He et al treated a similar case of metastatic retroperitoneal paraganglioma with resection of the vertebral metastasis and posterior fixation surgery. To avoid serious complications associated with surgical resection, our team concluded that the best appropriate initial case management would be radiosurgery and somatostatin analogs treatment. Although the ideal final treatment remains unclear, concomitant treatment with radiosurgery and reconstructive surgery has appeared to be both safe and effective [12]. Somatostatin analogs have been an effective complementary treatment for metastatic paragangliomas as well [13]. Hruby et al stated that external beam radiotherapy, chemotherapy and 131I metaiodobenzylguanidine can be effective treatment options [14]. Further studies should examine the efficacy and safety of the existing therapeutic approaches regarding the metastatic to the spine retroperitoneal paraganglioma.

 

 

In conclusion, we report a case of a functional extra-adrenal paraganglioma of the retroperitoneum giving vertebral metastases five years after the complete removal of the primary site. Malignant paraganglioma with spinal metastases is a rare presentation and metastases' appearance can vary from months to many years after the initial diagnosis. Imaging modalities have crucial role in the diagnosis and evaluation of spinal metastatic disease. Treatment should be individualized according to each patient and surveillance with clinical assessment, imaging tests and long-term follow-up is mandatory in patients with history of retroperitoneal paraganglioma. Finally, the combination of aggressive behaviour and delayed reappearance is something that we should keep in mind; and certainly this case represents a good example.

 

 

The authors declare no competing interests.

 

 

Stylianos Kapetanakis prepared, organized and edited all aspects of the manuscript. Danai Chourmouzi collected and critically analyzed all the radiological findings. Grigorios Gkasdaris wrote and joined together all aspects of the case forming the main skeleton of the article. Vasileios Katsaridis examined the patient and performed the neurosurgical intervention. Eleftherios Eleftheriadis performed the gross and histologic evaluation of the pathology specimen. Panagiotis Givissis critically evaluated the whole article and the relevant literature. All the authors have made substantial contributions to conception and design, acquisition of data and data analysis, drafting of the article and critical evaluation and approval of the version to be published.

 

 

Figure 1: (A) CT scan depicts an expansile lytic lesion in T6 vertebra that destroys the cortex of the vertebral body (arrows), Sagittal; (B) and axial; (C) fat-saturated (FS) T1-weighted MRI with intravenous gadolinium contrast demonstrates compression fracture of vertebral body and the extent of disease in the marrow cavity, soft tissues and epidural space; (D) computed tomography guided needle biopsy

Figure 2: (A) tumor cells arranged in solid nests with increased number of mitoses; (B) tumor cells positive for chromogranin A

Figure 3: MRI of the lumbar spine, sagittal section, T1: (A) T2; (B) and gadolinium-enhanced T1-weighted; (C) sequences: presence of nodular bone metastases with a halo (arrows)

 

 

1. Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocrine-Related Cancer. 2007; 14(3): 569-85. PubMed | Google Scholar


2. Razakaboay M, Maillefert JF, Wendling D, Juvin R, Toussirot E, Tavernier C et al. Bone metastases from a paraganglioma: a review of five cases. Revue du Rhumatisme English Edition. 1999; 66(2): 86-91. PubMed | Google Scholar


3. He J, Wang X, Zheng W, Zhao Y. Retroperitoneal paraganglioma with metastasis to the abdominal vertebra: a case report. Diagn Pathol. 2013 Mar 28; 8: 52. PubMed | Google Scholar


4. Tischler AS. Pheochromocytoma and extra-adrenal paraganglioma: updates. Archives of Pathology and Laboratory Medicine. 2008; 132(8): 1272-84. PubMed | Google Scholar


5. Saddoud N, Turki I, Chammakhi R, Ben Reguiga M, Nouira K, Menif E. Malignant paraganglioma with vertebral and skull metastasis. J Radiol. 2006; 87(12 Pt 1): 1887-90. PubMed | Google Scholar


6. Kitagawa R, Murakami H, Kato S, Nakada M, Demura S, Tsuchiya H. En Bloc Resection and Reconstruction Using a Frozen Tumor-Bearing Bone for Metastases of the Spine and Cranium from Retroperitoneal Paraganglioma. World Neurosurg. 2016; 90: 698. PubMed | Google Scholar


7. Doza F, Majumder AS, Rahman MM, Akhter MQ, Nahar K, Hossain MF. Malignant paraganglioma: a case report. Mymensingh Med J. 2014; 23(2): 384-8. PubMed | Google Scholar


8. Shah LM, Salzman KL. Imaging of spinal metastatic disease. Int J Surg Oncol. 2011; 2011: 769753. PubMed | Google Scholar


9. Kaltsikis I, Chourmouzi D, Drevelegas K, Potsi S, Moumtzouoglou A, Drevelegas A. Core needle biopsy of spinal lesions under CT guidance: review of 79 cases. J Neurol Surg A Cent Eur Neurosurg. 2012; 73(4): 199-203. PubMed | Google Scholar


10. Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer. 2007; 14(3): 569-85. PubMed | Google Scholar


11. Lázaro B, Klemz M, Flores MS, Landeiro JA. Malignant paraganglioma with vertebral metastasis: case report. Arq Neuropsiquiatr. 2003; 61(2B): 463-7. PubMed | Google Scholar


12. Sasaki K, Inose H, Kawabata S, Yoshii T, Kato T, Saito M, Okawa A. Combined surgical and radiosurgical treatment for a symptomatic cervical metastasis in a case of malignant paraganglioma: a case report. BMC Res Notes. 2013; 6: 494. PubMed | Google Scholar


13. Tonyukuk V, Emral R, Temizkan S, Sertcelik A, Erden I, Corapcioglu D. Case report: patient with multiple paragangliomas treated with long acting somatostatin analogue. Endocrine Journal. 2003; 50(5): 507-13. PubMed | Google Scholar


14. Hruby G, Lehman M, Barton M, Peduto T. Malignant retroperitoneal paraganglioma: case report and review of treatment options. Journal of Medical Imaging and Radiation Oncology. 2000; 44(4): 478-482. PubMed | Google Scholar